These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31794072)

  • 21. Efficacy of the triple-combination SM-1 in a 5-h phase advance transient insomnia model.
    Dahl T; Zammit G; Ahmad M; Rosenberg R; Chen LB; Roth T
    Sleep Biol Rhythms; 2022 Jan; 20(1):47-52. PubMed ID: 38469063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.
    Blin O; Micallef J; Audebert C; Legangneux E
    J Clin Psychopharmacol; 2006 Jun; 26(3):284-9. PubMed ID: 16702893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and pharmacodynamic analysis of sedative and amnesic effects of lorazepam in healthy volunteers.
    Blin O; Simon N; Jouve E; Habib M; Gayraud D; Durand A; Bruguerolle B; Pisano P
    Clin Neuropharmacol; 2001; 24(2):71-81. PubMed ID: 11307041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem.
    Drover D; Lemmens H; Naidu S; Cevallos W; Darwish M; Stanski D
    Clin Ther; 2000 Dec; 22(12):1443-61. PubMed ID: 11192136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo.
    Bensimon G; Foret J; Warot D; Lacomblez L; Thiercelin JF; Simon P
    Br J Clin Pharmacol; 1990 Sep; 30(3):463-9. PubMed ID: 2223425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carryover effect on next-day sleepiness and psychomotor performance of nighttime administered antihistaminic drugs: a randomized controlled trial.
    Katayose Y; Aritake S; Kitamura S; Enomoto M; Hida A; Takahashi K; Mishima K
    Hum Psychopharmacol; 2012 Jul; 27(4):428-36. PubMed ID: 22806823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of zolpidem after oral administration of a single dose in dogs.
    Giorgi M; Portela DA; Breghi G; Briganti A
    Am J Vet Res; 2012 Oct; 73(10):1650-6. PubMed ID: 23013193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zolpidem 10 mg given at daytime is not antagonized by 300 mg caffeine in man.
    Mattila MJ; Nurminen ML; Vainio P; Vanakoski J
    Eur J Clin Pharmacol; 1998 Jul; 54(5):421-5. PubMed ID: 9754987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rifampicin markedly decreases plasma concentration and hypnotic effect of brotizolam.
    Ujiie Y; Fukasawa T; Yasui-Furukori N; Suzuki A; Tateishi T; Otani K
    Ther Drug Monit; 2006 Jun; 28(3):299-302. PubMed ID: 16778710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
    Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
    Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers.
    Paterson LM; Nutt DJ; Ivarsson M; Hutson PH; Wilson SJ
    J Psychopharmacol; 2009 Jul; 23(5):487-94. PubMed ID: 19351801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteers.
    Scavone JM; Greenblatt DJ; Harmatz JS; Engelhardt N; Shader RI
    J Clin Pharmacol; 1998 Jul; 38(7):603-9. PubMed ID: 9702844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of zolpidem/triazolam on cognitive performance 12 hours after acute administration.
    Matsunaga Y; Tagaya H; Fukase Y; Hakamata Y; Murayama N; Kumagai Y; Kuroyama M
    Sleep Med; 2018 Dec; 52():213-218. PubMed ID: 30097333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder.
    Saletu-Zyhlarz G; Anderer P; Brandstätter N; Dantendorfer K; Gruber G; Mandl M; Ritter K; Zoghlami A; Saletu B
    Neuropsychobiology; 2000; 41(3):139-48. PubMed ID: 10754428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of zolpidem on saccadic eye movements and psychomotor performance: a double-blind, placebo controlled study in healthy volunteers.
    Richens A; Mercer AJ; Jones DM; Griffiths A; Marshall RW
    Br J Clin Pharmacol; 1993 Jul; 36(1):61-5. PubMed ID: 8373713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.
    Troy SM; Lucki I; Unruh MA; Cevallos WH; Leister CA; Martin PT; Furlan PM; Mangano R
    J Clin Psychopharmacol; 2000 Jun; 20(3):328-37. PubMed ID: 10831020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sedative, memory, and performance effects of hypnotics.
    Roehrs T; Merlotti L; Zorick F; Roth T
    Psychopharmacology (Berl); 1994 Oct; 116(2):130-4. PubMed ID: 7862941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daytime sleep and performance following a zolpidem and melatonin cocktail.
    Wesensten NJ; Balkin TJ; Reichardt RM; Kautz MA; Saviolakis GA; Belenky G
    Sleep; 2005 Jan; 28(1):93-103. PubMed ID: 15700725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.
    Voderholzer U; Riemann D; Hornyak M; Backhaus J; Feige B; Berger M; Hohagen F
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):117-23. PubMed ID: 11697572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.